QL-X-138 HCl
Product Specifications
Target
MNK, BTK
Related Pathways
Angiogenesis, MAPK, Tyrosine Kinase/Adaptors
Purity
0.9925
Bioactivity
QL-X-138 HCl is a novel selective and highly potent BTK/MNK dual-kinase inhibitor with anticancer activity that binds covalently to BTK and noncovalently to MNK. QL-X-138 HCl inhibited BTK, MNK1, and MNK2 kinases. QL-X-138 HCl has anti-dengue virus 2 activity and shows anti-proliferative activity in acute myeloid leukemia cells. QL-X-138 HCl can be used to study lymphoma and leukemia.
Smiles
O=C(NC1=CC(N2C(C=CC3=CN=C4C=CC(C5=CNN=C5)=CC4=C32)=O)=CC=C1C)C=C.Cl[H]
Molecular Formula
C25H20ClN5O2
Molecular Weight
457.91
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1164329 Inquire
Recombinant Acidiphilium cryptum Polyphosphate kinase (ppk), partial
Sign In for Pricing
View Details GTR15307956 1 Vial
Lentiviral human LONP2 shRNA (UAS) - Lentiviral human LONP2 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details